Nektar Therapeutics
NKTR
NKTR
203 hedge funds and large institutions have $3.69B invested in Nektar Therapeutics in 2017 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 84 increasing their positions, 59 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
203
Holders Change
+6
Holders Change %
+3.05%
% of All Funds
5.07%
Holding in Top 10
8
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+100%
% of All Funds
0.2%
New
24
Increased
84
Reduced
59
Closed
16
Calls
$33.9M
Puts
$8.97M
Net Calls
+$24.9M
Net Calls Change
+$3.88M
Top Buyers
1 |
Janus Henderson Group
London,
United Kingdom
|
+$37.4M |
2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$23.9M |
3 |
BlackRock
New York
|
+$18.7M |
4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$17.9M |
5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$8.75M |
Top Sellers
1 |
PP
PDT Partners
New York
|
-$13M |
2 |
BM
Bridger Management
New York
|
-$12.9M |
3 |
O
OppenheimerFunds
New York
|
-$11.6M |
4 |
State Street
Boston,
Massachusetts
|
-$10.6M |
5 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$9.67M |